Gene expression in human osteoblastic cells from normal and heterotopic ossification

被引:21
作者
Chauveau, C
Devedjian, JC
Blary, MC
Delecourt, C
Hardouin, P
Jeanfils, J
Broux, O
机构
[1] Univ Littoral Cote Opale, Lab Rech Biomat & Biotechnol LR2B, F-62327 Boulogne Sur Mer, France
[2] Univ Littoral Cote Opale, Lab Rech Biomat & Biotechnol LR2B, F-62327 Berck Sur Mer, France
[3] Etab Helio Marin, Grp Hopale, Berck Sur Mer, France
关键词
heterotopic ossification; head injury; quantitative RT-PCR; osteocalcin mRNA;
D O I
10.1016/j.yexmp.2003.10.001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Heterotopic ossification (HO), a possible complication of head injury, develops in sites where it is not normally present like at the vicinity of joints. It may cause pain, decrease motion and in severe cases complete joint ankylosis requiring surgical intervention. To our knowledge, no study has been made to analyze HO at the molecular level on human biopsies, whereas its etiology remains to be determined. We defined a procedure of cell fractionation from bone resections and developed quantitative RT-PCR to compare genetic expression patterns between human normal osteoblasts and heterotopic ossification forming cells. This quantitative study demonstrated a specific and strong overexpression of osteocalcin mRNA in HO-isolated cells associated with a significant upregulation of type 1 collagen and osteonectin mRNA while histological analysis showed only small cellular variations. Our results give a first molecular characterization of heterotopic ossification and we conclude that such overexpressions in HO-isolated cells could be associated with the high activity of this pathological bone. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 22 条
[1]   The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105) [J].
Barry, FP ;
Boynton, RE ;
Haynesworth, S ;
Murphy, JM ;
Zaia, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :134-139
[2]   EVIDENCE FOR A HUMORAL MECHANISM FOR ENHANCED OSTEOGENESIS AFTER HEAD-INJURY [J].
BIDNER, SM ;
RUBINS, IM ;
DESJARDINS, JV ;
ZUKOR, DJ ;
GOLTZMAN, D .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1990, 72A (08) :1144-1149
[3]   Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone [J].
Bord, S ;
Horner, A ;
Beeton, CA ;
Hembry, RM ;
Compston, JE .
BONE, 1999, 24 (03) :229-235
[4]   OSTEOMA CUTIS AND ALBRIGHTS HEREDITARY OSTEODYSTROPHY [J].
BROOK, CGD ;
BALMAN, HB .
BRITISH JOURNAL OF DERMATOLOGY, 1971, 85 (05) :471-+
[5]   THE NATURAL-HISTORY OF HETEROTOPIC OSSIFICATION IN PATIENTS WHO HAVE FIBRODYSPLASIA OSSIFICANS PROGRESSIVA - A STUDY OF 44 PATIENTS [J].
COHEN, RB ;
HAHN, GV ;
TABAS, JA ;
PEEPER, J ;
LEVITZ, CL ;
SANDO, A ;
SANDO, N ;
ZASLOFF, M ;
KAPLAN, FS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1993, 75A (02) :215-219
[6]   Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation [J].
Ducy, P ;
Zhang, R ;
Geoffroy, V ;
Ridall, AL ;
Karsenty, G .
CELL, 1997, 89 (05) :747-754
[7]   An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression [J].
Giulietti, A ;
Overbergh, L ;
Valckx, D ;
Decallonne, B ;
Bouillon, R ;
Mathieu, C .
METHODS, 2001, 25 (04) :386-401
[8]   CELL-SURFACE ANTIGENS ON HUMAN MARROW-DERIVED MESENCHYMAL CELLS ARE DETECTED BY MONOCLONAL-ANTIBODIES [J].
HAYNESWORTH, SE ;
BABER, MA ;
CAPLAN, AI .
BONE, 1992, 13 (01) :69-80
[9]   Operative treatment of heterotopic hip ossification in patients with coma after brain injury [J].
Ippolito, E ;
Formisano, R ;
Caterini, R ;
Farsetti, P ;
Penta, F .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1999, (365) :130-138
[10]   PROGRESSIVE OSSEOUS HETEROPLASIA - A DISTINCT DEVELOPMENTAL DISORDER OF HETEROTOPIC OSSIFICATION - 2 NEW CASE-REPORTS AND FOLLOW-UP OF 3 PREVIOUSLY REPORTED CASES [J].
KAPLAN, FS ;
CRAVER, R ;
MACEWEN, GD ;
GANNON, FH ;
FINKEL, G ;
HAHN, G ;
TABAS, J ;
GARDNER, RJM ;
ZASLOFF, MA .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1994, 76A (03) :425-436